BRCA1 and breast neoplasm: Sections from patients with various BRCA1 mutations, including M1775R and C64G (reported to have a similar defect in ubiquitin-ligase activity as the synthetic I26A mutation [43]), and patients with normal BRCA1 breast tumors were examined.